Page last updated: 2024-10-24

busulfan and Metabolic Syndrome

busulfan has been researched along with Metabolic Syndrome in 1 studies

Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oudin, C1
Auquier, P1
Bertrand, Y1
Contet, A1
Kanold, J1
Sirvent, N1
Thouvenin, S1
Tabone, MD1
Lutz, P1
Ducassou, S1
Plantaz, D1
Dalle, JH1
Gandemer, V1
Beliard, S1
Berbis, J1
Vercasson, C1
Barlogis, V1
Baruchel, A1
Leverger, G1
Michel, G1

Other Studies

1 other study available for busulfan and Metabolic Syndrome

ArticleYear
Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study.
    Bone marrow transplantation, 2015, Volume: 50, Issue:11

    Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemother

2015